TipRanks
Medi Assist Healthcare Services Limited (IN:MEDIASSIST)
:MEDIASSIST
India Market
Want to see IN:MEDIASSIST full AI Analyst Report?

Medi Assist Healthcare Services Limited (MEDIASSIST) AI Stock Analysis

3 Followers

Top Page

IN:MEDIASSIST

Medi Assist Healthcare Services Limited

(MEDIASSIST)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
₹365.00
▲(7.45% Upside)
Action:Reiterated
Date:08/17/26
The score is supported primarily by strong financial fundamentals—especially solid revenue growth and a strong, low-leverage balance sheet. However, weak technical trend/momentum and mixed cash-flow conversion (along with some margin compression) materially reduce the overall rating, while valuation appears moderate-to-premium based on the current P/E.
Positive Factors
Strong revenue growth
Revenue growth of 27.4% demonstrates strong expansion in the company’s administered business. Sustained growth in covered lives, policies, claims volumes or client relationships can support durable operating scale over the next several quarters.
Negative Factors
Margin compression
Profitability is positive but weakening margins show that recent revenue growth is producing less operating leverage. If pricing, claims complexity or service costs remain elevated, earnings growth may continue to lag revenue growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Revenue growth of 27.4% demonstrates strong expansion in the company’s administered business. Sustained growth in covered lives, policies, claims volumes or client relationships can support durable operating scale over the next several quarters.
Read all positive factors

Medi Assist Healthcare Services Limited (MEDIASSIST) vs. iShares MSCI India ETF (INDA)

Medi Assist Healthcare Services Limited Business Overview & Revenue Model

Company Description
Medi Assist Healthcare Services is a health-tech and insur-tech company that provides third-party administration (TPA) services to insurance companies. It serves as an intermediary between insurance companies and policyholders, insurance companies...
How the Company Makes Money
MEDIASSIST primarily makes money by providing outsourced health benefits administration services to healthcare payers (such as insurance companies and employers/corporates running group health plans). Its core revenue is typically earned through s...

Medi Assist Healthcare Services Limited Financial Statement Overview

Summary
Strong revenue growth and a conservatively financed balance sheet (low latest debt-to-equity) support a solid financial profile. Offsetting this, profitability has seen margin compression and cash-flow quality is mixed, with volatile free cash flow and weaker conversion versus net income in the latest year.
Income Statement
68
Positive
Balance Sheet
83
Very Positive
Cash Flow
56
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.51B9.05B7.23B6.35B5.05B3.94B
Gross Profit3.13B5.11B4.17B2.62B2.12B1.98B
EBITDA1.78B1.79B1.78B1.31B1.33B1.12B
Net Income932.44M878.89M908.79M669.39M740.59M642.18M
Balance Sheet
Total Assets0.0013.72B11.58B8.51B7.06B6.02B
Cash, Cash Equivalents and Short-Term Investments2.39B2.39B4.56B2.33B2.54B2.50B
Total Debt0.00543.98M2.04B263.31M306.79M274.78M
Total Liabilities-8.52B5.20B6.06B3.69B3.22B2.63B
Stockholders Equity8.52B8.39B5.41B4.72B3.77B3.37B
Cash Flow
Free Cash Flow0.00521.21M922.93M479.57M534.10M527.03M
Operating Cash Flow0.001.08B1.38B663.81M810.79M643.99M
Investing Cash Flow0.00-1.64B-2.18B-548.64M-104.88M-828.99M
Financing Cash Flow0.00264.67M1.12B-147.55M-315.25M-303.71M

Medi Assist Healthcare Services Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹317.91B59.330.83%14.29%5.55%
69
Neutral
₹321.18B39.0920.55%42.94%
59
Neutral
₹23.31B25.230.62%27.41%-6.29%
59
Neutral
₹120.40B60.240.34%21.80%31.84%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
52
Neutral
₹78.83B37.2616.79%17.67%
49
Neutral
₹147.10B40.6138.81%151.01%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MEDIASSIST
Medi Assist Healthcare Services Limited
321.35
-213.77
-39.95%
IN:LALPATHLAB
Dr. Lal PathLabs Limited
1,926.70
204.54
11.88%
IN:MEDPLUS
MedPlus Health Services Ltd.
654.05
-186.65
-22.20%
IN:METROPOLIS
Metropolis Healthcare Ltd.
585.30
53.94
10.15%
IN:NIVABUPA
Niva Bupa Health Insurance Company Limited
79.63
-2.78
-3.37%
IN:STARHEALTH
Star Health & Allied Insurance Co. Ltd.
560.00
111.15
24.76%

Medi Assist Healthcare Services Limited Corporate Events

Medi Assist files Q1 FY27 investor presentation with Indian exchanges
Aug 9, 2026
Medi Assist Healthcare Services Limited has released its investor presentation for the first quarter of fiscal year 2027, in line with regulatory requirements for listed entities in India. The document has been shared with both the National Stock ...
Medi Assist Q1 FY27 Revenue Jumps 24% as Paramount Integration Nears Completion
Aug 9, 2026
Medi Assist reported a 24.1% year-on-year rise in operating revenue to ₹236.5 crore in Q1 FY27, with EBITDA up 14.3% and reported PAT up 21.9%, even as margins softened slightly. The company grew India health premiums under management by 26....
Medi Assist Publishes Quarterly Unaudited Results in Newspapers
Aug 9, 2026
Medi Assist Healthcare Services Limited published newspaper advertisements detailing the extract of its unaudited financial results for the quarter ended June 30, 2026, in the English daily Business Line and the Marathi daily Navshakti, as require...
Medi Assist Raises Mayfair We Care Stake to 91.75% and Reshapes UK Leadership
Jul 1, 2026
Medi Assist Healthcare Services Limited has completed the acquisition of an additional 31.75% stake in its UK subsidiary Mayfair We Care Limited through a share transfer from existing shareholders, for a total consideration of about Rs. 7.57 crore...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 17, 2026